Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.04 | 46.83 |
| PEG Ratio (TTM) | -0.01 | 0.69 |
| P/S Ratio (TTM) | 0.03 | 18.39 |
| P/B Ratio (TTM) | 0.00 | 15.82 |
| P/FCF Ratio (TTM) | -0.07 | 40.42 |
| Price to 5YR AVG Earnings Ratio | N/A | 72.22 |
| Price to 5YR AVG FCF Ratio | N/A | 98.26 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.07% | -2.87% |
| ROE (TTM) | -0.21% | 9.30% |
| Net Profit Margin (TTM) | -0.54% | 4.22% |
| ROIC 5YR AVG | N/A | 5.38% |
Growth (2%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -17.84% | N/A | N/A |
| Revenue | 1.14% | N/A | N/A |
| Net Income | -23.91% | N/A | N/A |
| Cash Flow | -57.44% | N/A | N/A |
Health (21%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.02 | 1.87 |
| Quick Ratio (TTM) | 0.02 | 1.86 |
| D/E Ratio (TTM) | 0.00 | 0.52 |
| Interest Coverage (TTM) | -3.71 | 12.71 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | N/A | 10.59 |
| LTL to 5YR AVG FCF | N/A | 3.83 |
| Shares Outstanding Growth 5YR AVG | N/A | 53.63% |